alphabrinzima

Alphabrinzima is an ophthalmic suspension used primarily to lower elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. It belongs to the class of carbonic anhydrase inhibitors. By reducing the production of aqueous humor in the eye, it effectively helps in managing pressure levels to prevent potential optic nerve damage and vision loss. This medication is typically prescribed by ophthalmologists and requires careful administration to ensure therapeutic efficacy and patient safety.